AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12627926 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 20
Study 10528097 — intervention group
Group type: EXPERIMENTAL
Intervention: Two consecutive doses of 50 microg salbutamol inhaled via Turbuhaler
Number of subjects: 17
Study 10528097 — intervention group
Group type: EXPERIMENTAL
Intervention: Two divided doses of 50 microg salbutamol inhaled via Turbuhaler with 1.5 min between doses
Number of subjects: 17
Study 10528097 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic doses of salbutamol via Turbuhaler
Number of subjects: 17
Study 8921921 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve conduction studies (NCS) in patients with RA
Number of subjects: 52
Study 8921921 — intervention group
Group type: COMPARATOR
Intervention: Nerve conduction studies (NCS) in healthy controls
Number of subjects: 52
Study 1884725 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine-ER tablets (once daily)
Number of subjects: 24
Study 1884725 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine capsules (t.d.s.)
Number of subjects: 24
Study 1884725 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 1884725 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine-ER tablets
Number of subjects: 24
Study 1884725 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine capsules
Number of subjects: 24
Study 6846300 — intervention group
Group type: EXPERIMENTAL
Intervention: Antacid tablets (14 mEq neutralizing capacity per tablet)
Number of subjects: 37
Study 6846300 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 31605880 — intervention group
Group type: EXPERIMENTAL
Intervention: Stature-group-specific equations based on tibial lengths
Number of subjects: 495
Study 31605880 — intervention group
Group type: COMPARATOR
Intervention: General equation with all participants of the study group
Number of subjects: 495
Study 31605880 — intervention group
Group type: EXPERIMENTAL
Intervention: Equations tested in cross-validation group for stature <185.9cm
Number of subjects: 495
Study 30054164 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 577
Study 28846633 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstituted freeze-dried strawberry beverage (50 g/day)
Number of subjects: 17
Study 28846633 — intervention group
Group type: COMPARATOR
Intervention: Control beverage
Number of subjects: 17
Study 26244985 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus bevacizumab (176 patients)
Number of subjects: 370
Study 26244985 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy only (194 patients)
Number of subjects: 370
Study 26244985 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus bevacizumab (high LDH subgroup)
Number of subjects: 370
Study 26244985 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy only (high LDH subgroup)
Number of subjects: 370
Study 24014834 — intervention group
Group type: EXPERIMENTAL
Intervention: MitraClip therapy
Number of subjects: 881
Study 24014834 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 881
Study 20337570 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect language therapy delivered by school staff using a consultancy model
Number of subjects: 0
Study 20337570 — intervention group
Group type: COMPARATOR
Intervention: Manualized language therapy delivered by speech and language therapists or assistants
Number of subjects: 0
Study 19108423 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupotomy-injection combined with Feng's spinal manipulation (FSM)
Number of subjects: 72
Study 19108423 — intervention group
Group type: COMPARATOR
Intervention: Traction (control group)
Number of subjects: 72
Study 19108423 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 72
Study 16580444 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate administered to increase plasma levels 1(1/2) to 2 times normal during cardiopulmonary bypass, n = 174
Number of subjects: 350
Study 16580444 — intervention group
Group type: COMPARATOR
Intervention: No intervention (placebo), n = 176
Number of subjects: 350
Study 16580444 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 350
Study 16580444 — intervention group
Group type: COMPARATOR
Intervention: Magnesium sulfate and placebo
Number of subjects: 350
Study 14738639 — intervention group
Group type: EXPERIMENTAL
Intervention: HydroThermAblator (HTA)
Number of subjects: 276
Study 14738639 — intervention group
Group type: COMPARATOR
Intervention: rollerball (RB)
Number of subjects: 276
Study 10902991 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy supplement (E) = 1171 kJ + 12 mg iron
Number of subjects: 136
Study 10902991 — intervention group
Group type: COMPARATOR
Intervention: Control (M) = 12 mg iron + 209 kJ
Number of subjects: 136
Study 10902991 — intervention group
Group type: COMPARATOR
Intervention: Control (S) = 104 kJoule
Number of subjects: 136
Study 10902991 — intervention group
Group type: COMPARATOR
Intervention: Control (M) and (S)
Number of subjects: 136
Study 9127847 — intervention group
Group type: EXPERIMENTAL
Intervention: Brace group (rehabilitation orthosis for 12 weeks postoperatively)
Number of subjects: 60
Study 9127847 — intervention group
Group type: COMPARATOR
Intervention: No-brace group (mobilized immediately, crutches discarded 2 weeks postoperatively)
Number of subjects: 60
Study 8436004 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical termination of pregnancy
Number of subjects: 113
Study 8436004 — intervention group
Group type: COMPARATOR
Intervention: Medical termination of pregnancy with mifepristone (200 mg) and gemeprost (1 mg)
Number of subjects: 113
Study 8436004 — intervention group
Group type: COMPARATOR
Intervention: Medical termination of pregnancy with mifepristone (400 mg) and gemeprost (1 mg)
Number of subjects: 113
Study 8436004 — intervention group
Group type: COMPARATOR
Intervention: Medical termination of pregnancy with mifepristone (600 mg) and gemeprost (1 mg)
Number of subjects: 113
Study 2992530 — intervention group
Group type: EXPERIMENTAL
Intervention: suloctidil (Locton) at a daily dose of 200 mg X 3 for 180 days
Number of subjects: 15
Study 2992530 — intervention group
Group type: EXPERIMENTAL
Intervention: suloctidil (Locton)
Number of subjects: 15
Study 29970335 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed incision negative pressure therapy (ciNPT)
Number of subjects: 188
Study 29970335 — intervention group
Group type: COMPARATOR
Intervention: Standard wound dressings (control group)
Number of subjects: 188
Study 27866528 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV-NAVA
Number of subjects: 40
Study 27866528 — intervention group
Group type: COMPARATOR
Intervention: NIV-PSV
Number of subjects: 40
Study 26796449 — intervention group
Group type: EXPERIMENTAL
Intervention: Low toric IOL (Acrysof IQ SN6AT3 or SN6AT4)
Number of subjects: 39
Study 26796449 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-high toric IOL (Acrysof IQ SN6AT5, SN6AT6, SN6AT7, SN6AT8, or SN6AT9)
Number of subjects: 39
Study 26796449 — intervention group
Group type: EXPERIMENTAL
Intervention: Low toric IOL
Number of subjects: 39
Study 26796449 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-high toric IOL
Number of subjects: 39
Study 26796449 — intervention group
Group type: COMPARATOR
Intervention: Nontoric IOL (Acrysof SN60WF)
Number of subjects: 39
Study 22891564 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioiodine therapy (average 18.47 +/- 8.81 mCi)
Number of subjects: 27
Study 22891564 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioiodine therapy
Number of subjects: 27
Study 22891564 — intervention group
Group type: COMPARATOR
Intervention: Thiamazole treatment before radioiodine therapy
Number of subjects: 27
Study 20306010 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical trials for surgery
Number of subjects: 2249
Study 18550953 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent strength and endurance (CSE) training
Number of subjects: 16
Study 18550953 — intervention group
Group type: COMPARATOR
Intervention: Endurance-only (EO) training
Number of subjects: 16
Study 16009873 — intervention group
Group type: EXPERIMENTAL
Intervention: H pylori infection (measured by seropositivity) in patients with morbid obesity (181 [43.7%] of 414)
Number of subjects: 1097
Study 16009873 — intervention group
Group type: EXPERIMENTAL
Intervention: H pylori infection in younger age groups (10-19 years)
Number of subjects: 1097
Study 16009873 — intervention group
Group type: EXPERIMENTAL
Intervention: H pylori infection in age group 20-29 years
Number of subjects: 1097
Study 16009873 — intervention group
Group type: EXPERIMENTAL
Intervention: H pylori infection in age group 30-39 years
Number of subjects: 1097
Study 16009873 — intervention group
Group type: EXPERIMENTAL
Intervention: H pylori infection in age group 40 years or older
Number of subjects: 1097
Study 12421160 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 1000 mg
Number of subjects: 0
Study 12421160 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 375 mg
Number of subjects: 0
Study 12421160 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12037844 — intervention group
Group type: EXPERIMENTAL
Intervention: Home prenatal follow-up
Number of subjects: 0
Study 12037844 — intervention group
Group type: COMPARATOR
Intervention: Classical hospitalization
Number of subjects: 0
Study 7584685 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray (FPANS) 200 micrograms once or twice daily
Number of subjects: 0
Study 7584685 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate aqueous nasal spray (BPD) 200 micrograms twice daily
Number of subjects: 0
Study 7584685 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1955610 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 20
Study 1955610 — intervention group
Group type: COMPARATOR
Intervention: Cigarettes
Number of subjects: 20
Study 88189 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiotape slide programmes with synchronised automated apparatus
Number of subjects: 0
Study 88189 — intervention group
Group type: COMPARATOR
Intervention: Audiotape slide programmes with simple manual equipment
Number of subjects: 0
Study 30265563 — intervention group
Group type: EXPERIMENTAL
Intervention: RBO1 (4,000 ppm gamma-oryzanol)
Number of subjects: 59
Study 30265563 — intervention group
Group type: EXPERIMENTAL
Intervention: RBO2 (8,000 ppm gamma-oryzanol)
Number of subjects: 59
Study 30265563 — intervention group
Group type: EXPERIMENTAL
Intervention: RBO3 (11,000 ppm gamma-oryzanol)
Number of subjects: 59
Study 30265563 — intervention group
Group type: COMPARATOR
Intervention: Control (soybean oil)
Number of subjects: 59
Study 27927679 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon laser peripheral iridoplasty (ALPI)
Number of subjects: 22
Study 27927679 — intervention group
Group type: COMPARATOR
Intervention: No further treatment (Control)
Number of subjects: 22
Study 25646330 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding (duration and exclusivity categorized into low, intermediate, and high groups)
Number of subjects: 408
Study 23148551 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent electrical stimulation (CES)
Number of subjects: 11
Study 23148551 — intervention group
Group type: COMPARATOR
Intervention: No CES (placebo)
Number of subjects: 11
Study 17520566 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional heparinization (heparin 1500 IU/h pre-filter, protamine 15 mg/h post-filter)
Number of subjects: 10
Study 17520566 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional citrate anticoagulation (citrate-based replacement fluid 14 mmol/L pre-dilution)
Number of subjects: 10
Study 17520566 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 10
Study 14979842 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet education intervention (5 Internet documents on quality of care)
Number of subjects: 0
Study 14979842 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet education intervention with interaction with a nurse
Number of subjects: 0
Study 14979842 — intervention group
Group type: COMPARATOR
Intervention: Internet education intervention without interaction with a nurse
Number of subjects: 0
Study 11114960 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg day-1)
Number of subjects: 26
Study 11114960 — intervention group
Group type: COMPARATOR
Intervention: Cholestyramine (6 g three times a day)
Number of subjects: 26
Study 9339968 — intervention group
Group type: EXPERIMENTAL
Intervention: Notification by patients themselves within 2 days or by disease intervention specialists
Number of subjects: 1966
Study 9339968 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate notification by intervention specialist
Number of subjects: 1966
Study 9339968 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate notification by intervention specialists with option of drawing blood in the field
Number of subjects: 1966
Study 9339968 — intervention group
Group type: COMPARATOR
Intervention: All approaches
Number of subjects: 1966
Study 8264873 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH (25 micrograms i.v. bolus) during daytime studies
Number of subjects: 8
Study 8264873 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH (25 micrograms i.v. bolus) during night studies
Number of subjects: 8
Study 8264873 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH (25 micrograms i.v. bolus) during sleep studies
Number of subjects: 8
Study 8264873 — intervention group
Group type: COMPARATOR
Intervention: Saline (as control) during night studies
Number of subjects: 8
Study 3792425 — intervention group
Group type: EXPERIMENTAL
Intervention: 11R, 16, 16-trimethyl prostaglandin E2 (TmPGE2)
Number of subjects: 10
Study 30520111 — intervention group
Group type: EXPERIMENTAL
Intervention: 308-nm excimer laser combined with halometasone
Number of subjects: 0
Study 30520111 — intervention group
Group type: EXPERIMENTAL
Intervention: 308-nm excimer laser combined with tacrolimus
Number of subjects: 0
Study 30520111 — intervention group
Group type: EXPERIMENTAL
Intervention: 308-nm excimer laser combined with pimecrolimus
Number of subjects: 0
Study 30520111 — intervention group
Group type: COMPARATOR
Intervention: 308-nm excimer laser monotherapy
Number of subjects: 0
Study 29894473 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy individuals with low educational level
Number of subjects: 99497
Study 29894473 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy individuals who are housewives
Number of subjects: 99497
Study 29894473 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy individuals unable to work
Number of subjects: 99497
Study 29894473 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy individuals perceiving worse health status
Number of subjects: 99497
Study 29894473 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals with chronic disease with low educational level
Number of subjects: 99497
Study 29894473 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals with chronic disease with low household income
Number of subjects: 99497
Study 29894473 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals with chronic disease with ticket exemption
Number of subjects: 99497
Study 29894473 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals with chronic disease with fixed-term occupation
Number of subjects: 99497
Study 29894473 — intervention group
Group type: EXPERIMENTAL
Intervention: Former-smokers in both groups
Number of subjects: 99497
Study 27318749 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical CPR on a reducible stretcher (RS-CPR)
Number of subjects: 42
Study 27318749 — intervention group
Group type: COMPARATOR
Intervention: Manual CPR on a standard stretcher (SS-CPR)
Number of subjects: 42
Study 24711149 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral weight loss
Number of subjects: 378
Study 24711149 — intervention group
Group type: COMPARATOR
Intervention: Structured education programs
Number of subjects: 378
Study 22864881 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted colectomy (RAC)
Number of subjects: 70
Study 22864881 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopically assisted colectomy (LAC)
Number of subjects: 70
Study 19332518 — intervention group
Group type: EXPERIMENTAL
Intervention: Parotid gland-sparing intensity-modulated radiation therapy (IMRT)
Number of subjects: 10
Study 19332518 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiotherapy
Number of subjects: 10
Study 17897465 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise training four times a week for 12 months
Number of subjects: 48
Study 17897465 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone for 12 months
Number of subjects: 48
Study 15227764 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultural sensitivity training
Number of subjects: 247
Study 15227764 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 247
Study 11988379 — intervention group
Group type: EXPERIMENTAL
Intervention: bupropion
Number of subjects: 784
Study 11988379 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 784
Study 9793844 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (20 mg)
Number of subjects: 31
Study 9793844 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (25 mg)
Number of subjects: 31
Study 9793844 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term therapy with captopril (75 mg/day, n = 13)
Number of subjects: 31
Study 9793844 — intervention group
Group type: COMPARATOR
Intervention: Long-term therapy with nifedipine (40 mg/day, n = 12)
Number of subjects: 31
Study 7894825 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether administered intramuscularly twice daily (1.6 or 3.2 mg/kg/day)
Number of subjects: 47
Study 2558817 — intervention group
Group type: COMPARATOR
Intervention: Soluble insulin 0.15U/kg
Number of subjects: 8
Study 2558817 — intervention group
Group type: COMPARATOR
Intervention: Ovine CRF41 (oCRF41) 100 micrograms
Number of subjects: 8
Study 2558817 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble insulin 0.15U/kg followed by oCRF41 100 micrograms
Number of subjects: 8
Study 344108 — intervention group
Group type: EXPERIMENTAL
Intervention: Corynebacterium parvum (C.p.) 5 mg/sc/m2 on day 1 in addition to CAO/CMF
Number of subjects: 76
Study 344108 — intervention group
Group type: COMPARATOR
Intervention: Control group without C.p.
Number of subjects: 76
Study 30598342 — intervention group
Group type: EXPERIMENTAL
Intervention: Solriamfetol (300 mg) in fasted condition
Number of subjects: 32
Study 30598342 — intervention group
Group type: COMPARATOR
Intervention: Solriamfetol (300 mg) in fed condition
Number of subjects: 32
Study 30598342 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 32
Study 28115424 — intervention group
Group type: EXPERIMENTAL
Intervention: Schoolyard renovation, mandatory outdoor recess, increased adult supervision and support
Number of subjects: 0
Study 26322787 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 304
Study 26322787 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 304
Study 26322787 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance training
Number of subjects: 304
Study 26322787 — intervention group
Group type: COMPARATOR
Intervention: Non-exercising control
Number of subjects: 304
Study 23257975 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (10 mg/day)
Number of subjects: 202
Study 23257975 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg/day)
Number of subjects: 202
Study 20872083 — intervention group
Group type: EXPERIMENTAL
Intervention: Population-based informatics system implemented in intervention practices
Number of subjects: 6070
Study 20872083 — intervention group
Group type: COMPARATOR
Intervention: Control practices with standard electronic health record reminders
Number of subjects: 6070
Study 19996078 — intervention group
Group type: EXPERIMENTAL
Intervention: low-frequency repetitive transcranial magnetic stimulation (lfrTMS)
Number of subjects: 7
Study 19996078 — intervention group
Group type: EXPERIMENTAL
Intervention: continuous theta burst stimulation (cTBS)
Number of subjects: 7
Study 19996078 — intervention group
Group type: EXPERIMENTAL
Intervention: cathodal transcranial direct current stimulation (tDCS)
Number of subjects: 7
Study 17459480 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimatoprost
Number of subjects: 200
Study 17459480 — intervention group
Group type: COMPARATOR
Intervention: LTFC (Latanoprost and Timolol Fixed Combination)
Number of subjects: 200
Study 15226164 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD (n = 4348)
Number of subjects: 30865
Study 15226164 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression alone (n = 7580)
Number of subjects: 30865
Study 15226164 — intervention group
Group type: COMPARATOR
Intervention: Neither condition (n = 18,937)
Number of subjects: 30865
Study 11704081 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light therapy (BLT)
Number of subjects: 23
Study 11704081 — intervention group
Group type: COMPARATOR
Intervention: Dim light therapy (DLT)
Number of subjects: 23
Study 9606848 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant metalloproteins (superoxide dismutase, catalase, ceruloplasmin, transferrin)
Number of subjects: 0
Study 9606848 — intervention group
Group type: EXPERIMENTAL
Intervention: Prooxidant metalloproteins (cytochromes b5, b558III, b558IV, suprol)
Number of subjects: 0
Study 8199567 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cyclosporin (CsA)
Number of subjects: 91
Study 8199567 — intervention group
Group type: COMPARATOR
Intervention: Low-dose cyclosporin (CsA)
Number of subjects: 91
Study 8199567 — intervention group
Group type: COMPARATOR
Intervention: M1‐M3 FAB subtypes
Number of subjects: 91
Study 8199567 — intervention group
Group type: EXPERIMENTAL
Intervention: M4‐M6 FAB subtypes
Number of subjects: 91
Study 8199567 — intervention group
Group type: EXPERIMENTAL
Intervention: Long interval (> or = 180 days) between diagnosis and BMT
Number of subjects: 91
Study 8199567 — intervention group
Group type: EXPERIMENTAL
Intervention: Females
Number of subjects: 91
Study 3587902 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent multiagent chemotherapy and orbital radiation therapy after initial partial tumor resection
Number of subjects: 127